Skip to main content

A PHASE 3, MULTI-CENTER, MULTI-NATIONAL, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED INDUCTION AND MAINTENANCE STUDY TO EVALUATE THE EFFICACY AND SAFETY OF CC-93538 IN ADULT AND ADOLESCENT SUBJECTS WITH EOSINOPHILIC ESOPHAGITIS

Clinical Trial Grant
Duke Scholars

Administered By

Medicine, Gastroenterology

Awarded By

Celgene Corporation

Start Date

December 6, 2021

End Date

November 9, 2024
 

Administered By

Medicine, Gastroenterology

Awarded By

Celgene Corporation

Start Date

December 6, 2021

End Date

November 9, 2024